Ocugen, Inc. (OCGN): debt financing — Ocugen closes $130M of 6.75% convertible senior notes due 2034, net proceeds ~$112.6M

Ocugen, Inc.

Closed $130.0M aggregate principal of 6.75% Convertible Senior Notes due 2034, including full $15M over-allotment exercise.
Net proceeds ~$112.6M after discount and expenses; offering price was 90% of principal.
Used $32.7M to fully repay outstanding loan under Avenue Capital Group agreement plus prepayment fees.
Remaining net proceeds for general corporate purposes; cash runway extended into 2028.
CEO cites momentum to advance three late-stage programs targeting three BLA filings by 2028.

item 2.03 item 1.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Ocugen, Inc. incurred convertible notes of $15.0 million aggregate principal amount with U.S. Bank Trust Company, National Association at 6.75% maturing due 2034.

Instrument: convertible notes
Principal: $15.0 million aggregate principal amount
Counterparty: U.S. Bank Trust Company, National Association
Rate: 6.75%
Maturity: due 2034
Event: incurrence

Exact text from the filing

On May 14, 2026, the Company issued an additional $15.0 million aggregate principal amount of notes (the "additional notes") pursuant to the exercise in full of the over-allotment option granted by the Company to the initial purchaser in the offering.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Ocugen, Inc. entered into purchase agreement with initial purchaser (effective 2026-05-04).

Action: entry
Agreement: notes offering
Counterparty: initial purchaser
Effective: 2026-05-04

Exact text from the filing

The Company offered and sold the additional notes to the initial purchaser in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities

View on SEC.gov

Browse all debt financings →

Ocugen, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-061230

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.